輝瑞手冊和使用者指南

輝瑞產品的使用手冊、安裝指南、故障排除協助和維修資訊。

提示:為了獲得最佳匹配效果,請提供輝瑞藥品標籤上列印的完整型號。

輝瑞公司手冊

該品牌的最新貼文、精選手冊和零售商連結手冊 tag.

MEDROL 4mg Tablets by Pfizer User Guide

26 年 2026 月 XNUMX 日
MEDROL 4mg Tablets by Pfizer Specifications Chemical Name: Methylprednisolone Molecular Weight: 374.48 Available Tablet Strengths: 2 mg, 4 mg, 8 mg, 16 mg, 32 mg Inactive Ingredients: 2 mg Tablet: Calcium Stearate, Corn Starch, Erythrosine Sodium, Lactose, Mineral Oil, Sorbic…

輝瑞喹那普利 5 毫克片劑使用說明書

18 年 2025 月 XNUMX 日
輝瑞喹那普利 5 毫克錠警告:胎兒毒性 一旦發現懷孕,應盡快停用 ACCUPRIL。直接作用於腎素-血管張力素系統的藥物可能會對發育中的胎兒造成損傷甚至死亡。參見警告:胎兒毒性說明…

輝瑞 COVID-19 和流感家庭測試指導手冊

26 年 2024 月 XNUMX 日
新冠病毒和流感居家檢測產品規格:產品名稱:輝瑞 Lucira 新冠病毒和流感居家檢測產品;檢測類型:核酸檢測 Amplification Test (NAAT) Intended Use: For differential diagnosis of SARS-CoV-2, Influenza A, and Influenza B Viral Nucleic Acid Detection:…

輝瑞不良反應管理使用者指南

10 年 2024 月 XNUMX 日
Pfizer Adverse Reaction Management Management of Cytokine Release Syndrome (CRS) Identify CRS based on clinical presentation. Evaluate and treat other causes of fever, hypoxia, and hypotension. If CRS is suspected, withhold ELREXFIO until CRS resolves. Clinical signs and symptoms of…

輝瑞 Velsipity Etrasimod 潰瘍性結腸炎藥物說明書

24 年 2024 月 XNUMX 日
Pfizer Velsipity Etrasimod Ulcerative Colitis Drug Product Information Specifications Product Name: Velsipity Active Substance: Etrasimod Indication: Treatment of moderately to severely active ulcerative colitis in patients 16 years and older Mechanism of Action: Sphingosine-1-phosphate receptor  modulator Product Usage Instructions Velsipity…

輝瑞 BEQVEZ 軟體使用者指南

6 年 2024 月 XNUMX 日
Pfizer BEQVEZ Software Specifications Product Name: BEQVEZTM (fidanacogene elaparvovec-dzkt) injection Initial U.S. Approval: 2024 Indicated for: Adults with moderate to severe hemophilia B (congenital factor IX deficiency) Indications and Usage: BEQVEZ is a gene therapy for adults with hemophilia B…

輝瑞依西美坦 25 毫克包衣片說明

21 年 2022 月 XNUMX 日
包裝說明書:病人須知 依西美坦 25 毫克包衣錠 依西美坦 依西美坦 25 毫克包衣錠 服用此藥前,請仔細閱讀本說明書,因為它包含對您非常重要的資訊。請妥善保管本說明書。您…

CLEOCIN PHOSPHATE® (Clindamycin Injection, USP) Prescribing Information

Prescribing Information • March 30, 2026
Detailed prescribing information for CLEOCIN PHOSPHATE® (clindamycin injection, USP), an antibiotic used for serious bacterial infections. Covers indications, contraindications, warnings (including C. difficile-associated diarrhea and benzyl alcohol toxicity), dosage, administration, pharmacokinetics, adverse reactions, and drug interactions.

ALDACTONE® (Spironolactone) Prescribing Information - Heart Failure, Hypertension, Edema, Hyperaldosteronism

Prescribing Information • February 13, 2026
Official prescribing information for ALDACTONE® (spironolactone) tablets, detailing its uses in heart failure, hypertension, edema, and hyperaldosteronism, including comprehensive guidance on dosage, administration, contraindications, warnings, precautions, drug interactions, adverse reactions, specific populations, clinical studies, and storage.

優納辛®(Amp西林鈉/舒巴坦鈉注射用粉劑 - 安全資料表

安全資料表 • 2025年12月9日
Unasyn® 安全資料表Ampicillin Sodium/Sulbactam Sodium) Powder for Injection, providing comprehensive information on product identification, hazards, composition, first aid, fire-fighting, handling, storage, exposure controls, physical and chemical properties, stability, reactivity, toxicological information, ecological information, disposal, transport, and regulatory information.

TRAZIMERA(曲妥珠單抗-qyyp)處方資訊

處方資訊 • 2025年11月5日
TRAZIMERA (trastuzumab-qyyp) is a biosimilar to HERCEPTIN, indicated for the treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. It carries significant warnings for cardiomyopathy, infusion reactions, embryo-fetal toxicity, and pulmonary toxicity.